Aerosolized antibiotics have advantages, drawbacks for ICU pneumonia

11/12/2012 | Medscape (free registration)

Using aerosolized antibiotics with ventilator-associated pneumonia patients can help avoid systemic antimicrobial exposure, but there remain drawbacks. In this interview, Michael E. Klepser from Ferris State University College of Pharmacy, in Big Rapids, Mich., says there is a risk for bacteremia in patients. "There's also considerable variation in the ability of different nebulizers to deliver a drug to the patient. As a result, each nebulizer–antibiotic combination may need to be evaluated to determine the stability and delivery characteristics," Klepser said.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX